Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 70%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
Healthcare · Biological Products, (No Diagnostic Substances)
AI confidence 70% · prior close shown (market closed)
Limited proprietary earnings coverage for CABA yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 0d ago
CABA's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on CABA.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for Cabaletta Bio, Inc. (CABA) — events, not interpretation.
Research & analysis only — not investment advice.
Held in ETFsweight · est. sleeve dollars
Investment snapshot
CABA's AI investment thesis
Upgrade to Premium for CABA's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$2.16
Market cap
$365.37M
Profitable
—
Net income
—
FY Sep 13, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Healthcare · Biological Products, (No Diagnostic Substances)
Investment Snapshot above is the primary AlphaOS analysis for Cabaletta Bio, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Cabaletta Bio, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.